Inventor
Laurence R. Meyerson
Inventor
Las Vegas, NV, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
Y02ATechnologies for adaptation to climate change11%
A61BDiagnosis5%
A61LMethods or apparatus for sterilising materials or objects in general3%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data3%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,966,610Angiogenic treatment of ischemic heart disease202110,433,783Therapeutic angiogenesis for treating erectile conditions20199,968,292Therapeutic angiogenesis for treating erectile conditions20188,987,333'Composition and method for treating neurological disease'20158,895,615'Composition and method for treating neurological disease'20148,895,618'Composition and method for treating neurological disease'20148,895,617'Composition and method for treating neurological disease'20148,895,614'Composition and method for treating neurological disease'20148,895,616'Composition and method for treating neurological disease'20148,889,740'Composition and method for treating neurological disease'20148,796,337'Composition and method for treating neurological disease'20148,598,233'Method for administering an NMDA receptor antagonist to a subject'20138,580,858'Compositions for the treatment of CNS-related conditions'20138,426,472'Method and composition for administering an NMDA receptor antagonist to a subject'20138,389,578'Composition and method for treating neurological disease'20138,362,085'Method for administering an NMDA receptor antagonist to a subject'20138,338,486'Methods for the treatment of CNS-related conditions'20128,338,485'Compositions for the treatment of CNS-related conditions'20128,329,752'Composition for administering an NMDA receptor antagonist to a subject'20128,293,794'Methods and compositions for the treatment of CNS-related conditions'20128,283,379'Methods and compositions for the treatment of CNS-related conditions'20128,173,708'Method and composition for administering an NMDA receptor antagonist to a subject'20128,168,209'Method and composition for administering an NMDA receptor antagonist to a subject'20127,619,007'Method and composition for administering an NMDA receptor antagonist to a subject'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2015Patents assigned to ADAMAS PHARMACEUTICALS INC (21)· patent assignee history
2009–2015Based in Las Vegas, NV, US· patent location history
2012–2013Patents assigned to FULTZ TIMOTHY J (10)· patent assignee history
2012–2013Patents assigned to MEYERSON LAURENCE R (10)· patent assignee history
2012–2013Patents assigned to WENT GREGORY T (10)· patent assignee history
2012–2013Patents assigned to BURKOTH TIMOTHY S (3)· patent assignee history
2018–2021Based in Henderson, NV, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ADAMAS PHARMACEUTICALS INC | 21 | 2009–2015 |
| FULTZ TIMOTHY J | 10 | 2012–2013 |
| MEYERSON LAURENCE Rself | 10 | 2012–2013 |
| WENT GREGORY T | 10 | 2012–2013 |
| BURKOTH TIMOTHY S | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Las Vegas, NV, US | 21 | 2009–2015 |
| Henderson, NV, US | 3 | 2018–2021 |